Evidence map›Paper›PMID 26598524›Full record

ArticleThe Journal of biological chemistry2016

The Retinoblastoma Tumor Suppressor Protein (pRb)/E2 Promoter Binding Factor 1 (E2F1) Pathway as a Novel Mediator of TGFβ-induced Autophagy.

Juliana Korah, Lucie Canaff, Jean-Jacques Lebrun

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. BANCR: a cancer-related long non-coding RNA.American journal of cancer research · 2017
    Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Juliana KorahFrom the Department of Medicine, McGill University Health Center, Cancer Research Program, Montreal, Quebec H4A 3J1, Canada.
Lucie CanaffFrom the Department of Medicine, McGill University Health Center, Cancer Research Program, Montreal, Quebec H4A 3J1, Canada.
Jean-Jacques LebrunFrom the Department of Medicine, McGill University Health Center, Cancer Research Program, Montreal, Quebec H4A 3J1, Canada JJ.Lebrun@mcgill.ca.
McGill University · CA

Funding

Canadian Institutes of Health Research MOP-114904
6 · The paper itself

Abstract

TGFβ is a multifunctional cytokine that regulates cell proliferation, cell immortalization, and cell death, acting as a key homeostatic mediator in various cell types and tissues. Autophagy is a programmed mechanism that plays a pivotal role in controlling cell fate and, consequently, many physiological and pathological processes, including carcinogenesis. Although autophagy is often considered a pro-survival mechanism that renders cells viable in stressful conditions and thus might promote tumor growth, emerging evidence suggests that autophagy is also a tumor suppressor pathway. The relationship between TGFβ signaling and autophagy is context-dependent and remains unclear. TGFβ-mediated activation of autophagy has recently been suggested to contribute to the growth inhibitory effect of TGFβ in hepatocarcinoma cells. In the present study, we define a novel process of TGFβ-mediated autophagy in cancer cell lines of various origins. We found that autophagosome initiation and maturation by TGFβ is dependent on the retinoblastoma tumor suppressor protein/E2 promoter binding factor (pRb/E2F1) pathway, which we have previously established as a critical signaling axis leading to various TGFβ tumor suppressive effects. We further determined that TGFβ induces pRb/E2F1-dependent transcriptional activation of several autophagy-related genes. Together, our findings reveal that TGFβ induces autophagy through the pRb/E2F1 pathway and transcriptional activation of autophagy-related genes and further highlight the central relevance of the pRb/E2F1 pathway downstream of TGFβ signaling in tumor suppression.

Indexed as

AutophagyCarcinoma, HepatocellularCell Line, TumorCytokinesE2F1 Transcription FactorGene Expression Regulation, NeoplasticGenes, Tumor SuppressorHep G2 CellsHumansLiver NeoplasmsMicrotubule-Associated Proteinsp300-CBP Transcription FactorsPhagosomesPromoter Regions, GeneticRetinoblastoma ProteinSignal TransductionCytokinesE2F1 protein, humanE2F1 Transcription FactorMAP1LC3A protein, humanMicrotubule-Associated Proteinsp300-CBP Transcription FactorsRetinoblastoma ProteinTransforming Growth Factor betaautophagycancerhepatocellular carcinomaretinoblastoma protein (pRb, RB)transforming growth factor beta (TGF-β)tumor suppressor gene

Identifiers

PMID26598524
PMCPMC4732193
OpenAlexW2252515498

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.